Development of a competitive enzyme-linked immunosorbent assay for therapeutic drug monitoring of afatinib

Afatinib is an oral tyrosine kinase inhibitor (TKI) approved for treating advanced non-small cell lung cancer. It is necessary to develop a simple quantification method for TKIs in order to facilitate therapeutic drug monitoring (TDM) in clinical settings. This study sought to develop a simple and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Sogawa, Rintaro, Saita, Tetsuya, Yamamoto, Yuta, Kimura, Sakiko, Narisawa, Yutaka, Kimura, Shinya, Shin, Masashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Xi'an Jiaotong University 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355467/
https://www.ncbi.nlm.nih.gov/pubmed/30740257
http://dx.doi.org/10.1016/j.jpha.2018.09.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355467/
https://www.ncbi.nlm.nih.gov/pubmed/30740257
http://dx.doi.org/10.1016/j.jpha.2018.09.002

Ejemplares similares